An established practice in Queensland is the latest to join George & Matilda Eyecare (G&M) with more in the pipeline to be announced shortly, as the company celebrates its six-year anniversary. Read more
New Under Armour collection available at O-Show
Safilo is set to exclusively launch Under Armour’s eyewear collection into the Australian and New Zealand market at O-Show this month. Read more
Designs For Vision prepares for big O-Show presence
Advanced imaging equipment for chronic eye disease will feature on the Designs For Vision (DFV) booth at OSHOW2022, however the ophthalmic equipment supplier is expecting significant interest in its array of myopia management diagnostics. Read more
New code of conduct for Aussie optometrists
Optometry is one of 12 health professions that will be bound by the national regulator’s revised shared code of conduct which comes into effect on 29 June. Read more
Specsavers scheme sends recycled specs to Tonga
More than 100,000 spectacles collected through a Specsavers glasses recycling program have been donated to Tongans in need. Read more
Zeiss unveils FORUM Cloud Viewer
Zeiss has introduced a new cloud-based image viewing and collaboration tool to help facilitate cohesive care between primary and tertiary eyecare providers. Read more
Analysis the first to quantify Australia’s ocular toxoplasmosis rate
One in 150 Australians have retinal scars caused by the Toxoplasma parasite, according a new Flinders University analysis that has prompted calls for increased awareness about the risks of eating raw and undercooked meat. Read more
Poor eyesight could unfairly skew cognitive test results
Researchers at the University of South Australia have ascertained that millions of older people with poor vision are at risk of being misdiagnosed with mild cognitive impairments. Read more
CooperVision steps up sustainability commitment in Australia and New Zealand
All CooperVision one-day contact lenses distributed in Australia and New Zealand are now plastic neutral, the company has announced. Read more
New anti-VEGF therapies seeking Aussie approval
The suppliers of two new anti-VEGF therapies recently cleared in the US that work to reduce macular disease treatment burdens are seeking approval to list the treatments on the Australian Pharmaceutical Benefits Scheme (PBS). Read more